BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 34442469)

  • 1. A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond.
    Matsumoto Y; Fukumitsu N; Ishikawa H; Nakai K; Sakurai H
    J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The New Generation of Particle Therapy Focused on Boron Element (Boron Neutron Capture Therapy; BNCT) -The World's First Approved BNCT Drug].
    Nakashima H
    Yakugaku Zasshi; 2022; 142(2):155-164. PubMed ID: 35110452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of radiobiological studies for the advancement of boron neutron capture therapy (BNCT).
    Monti Hughes A
    Expert Rev Mol Med; 2022 Mar; 24():e14. PubMed ID: 35357286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between proton boron fusion therapy (PBFT) and boron neutron capture therapy (BNCT): a monte carlo study.
    Jung JY; Yoon DK; Barraclough B; Lee HC; Suh TS; Lu B
    Oncotarget; 2017 Jun; 8(24):39774-39781. PubMed ID: 28427153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.
    Matsuya Y; Fukunaga H; Omura M; Date H
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boron neutron capture therapy: Current status and future perspectives.
    Dymova MA; Taskaev SY; Richter VA; Kuligina EV
    Cancer Commun (Lond); 2020 Sep; 40(9):406-421. PubMed ID: 32805063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.
    Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
    Radiat Res; 2012 Jan; 177(1):59-68. PubMed ID: 21980958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Boron Neutron Capture Therapy: Its History and Current Challenges.
    Jin WH; Seldon C; Butkus M; Sauerwein W; Giap HB
    Int J Part Ther; 2022; 9(1):71-82. PubMed ID: 35774489
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Hideghéty K; Brunner S; Cheesman A; Szabó ER; Polanek R; Margarone D; Tőkés T; Mogyorósi K
    Anticancer Res; 2019 May; 39(5):2265-2276. PubMed ID: 31092418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Biological and Physical Basis of Boron Neutron Capture Therapy (BNCT) as a Promising Treatment Frontier in Breast Cancer.
    Seneviratne D; Advani P; Trifiletti DM; Chumsri S; Beltran CJ; Bush AF; Vallow LA
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of boron neutron capture therapy (BNCT) and the design and dosimetry of a high-intensity, 24 keV, neutron beam for BNCT research.
    Perks CA; Mill AJ; Constantine G; Harrison KG; Gibson JA
    Br J Radiol; 1988 Dec; 61(732):1115-26. PubMed ID: 3064858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Particle Therapy in Cancer Treatment-Current and Future Perspective].
    Ishikawa H; Nakai K; Nonaka T; Sakurai H
    Gan To Kagaku Ryoho; 2019 Aug; 46(8):1219-1225. PubMed ID: 31501360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particle radiotherapy in the era of radioimmunotherapy.
    Zhou Z; Guan B; Xia H; Zheng R; Xu B
    Cancer Lett; 2023 Jul; 567():216268. PubMed ID: 37331583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boron Neutron Capture Therapy in the Treatment of Recurrent Laryngeal Cancer.
    Haapaniemi A; Kankaanranta L; Saat R; Koivunoro H; Saarilahti K; Mäkitie A; Atula T; Joensuu H
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):404-410. PubMed ID: 26797537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
    Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geant4 beam model for boron neutron capture therapy: investigation of neutron dose components.
    Moghaddasi L; Bezak E
    Australas Phys Eng Sci Med; 2018 Mar; 41(1):129-141. PubMed ID: 29362987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron neutron capture therapy (BNCT): implications of neutron beam and boron compound characteristics.
    Wheeler FJ; Nigg DW; Capala J; Watkins PR; Vroegindeweij C; Auterinen I; Seppälä T; Bleuel D
    Med Phys; 1999 Jul; 26(7):1237-44. PubMed ID: 10435523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Boron Neutron Capture Therapy in Primary Central Nervous System Lymphoma: In Vitro and In Vivo Evaluation.
    Yoshimura K; Kawabata S; Kashiwagi H; Fukuo Y; Takeuchi K; Futamura G; Hiramatsu R; Takata T; Tanaka H; Watanabe T; Suzuki M; Hu N; Miyatake SI; Wanibuchi M
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility study on the use of 230 MeV proton cyclotron in proton therapy centers as a spallation neutron source for BNCT.
    Nobakht E; Fouladi N
    Rep Pract Oncol Radiother; 2019; 24(6):644-653. PubMed ID: 31719802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.